CellRebel Completes a Heavily Oversubscribed Financing Round
CellRebel, a Swedish analytics company within the telecommunication space, today announced that it has completed a new issue of shares. The company’s growth has been generating great interest among investors and the round was oversubscribed by almost 200%. The funding capital will enable CellRebel to grow its sales as well as continue developing their analytics platform with new use cases and capabilities. Existing shareholders, together with a few selected new investors participated in the round.
“I got really impressed by CellRebel’s innovative solution with unique capabilities for the telecom industry. Their solution solves real problems that I know all mobile operators are dealing with. This, together with a strong team, made me want to invest in the company and I look forward to be part of the company’s future journey as a shareholder.” says Lars Elfversson, one of the new investors.
“We are really happy and grateful for the trust in the company by existing shareholders and the strong interest from new investors. With the raised cash, we will continue to enhance our products and bring even more value to our customers with new features and functionality. We also have very ambitious targets going forward to scale our revenue” says Tibor Rathonyi, CEO of CellRebel.
About us:
CellRebel is a swedish company that offers advanced analytics solutions targeting mobile operators with capabilities in user experience and service quality monitoring, competitive intelligence, market analytics and subscriber behavior for network improvement, planning, optimization and revenue improvement actions. Our unique solution collects, analyzes and correlates large datasets and defines improvement actions with state-of-the-art technology based on 100+ billion daily data samples gathered from 10 000+ content/app providers, 800+ CDN/Cloud providers and 1+ billion Smartphones. The solution does not require any hardware to be deployed in the operator’s network.
For more information check:
Follow us:
linkedin.com/company/cellrebel
Tags:
